ArticleAdvanced healthcare materials2026
Tunicate-Inspired Carboxymethyl Cellulose Hydrogel Filler for Treating Age-Associated Vocal Fold Atrophy.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tunicate-Inspired Carboxymethyl Cellulose Hydrogel Filler for Treating Age-Associated Vocal Fold Atrophy.Advanced healthcare materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
For the treatment of dysphonia and aspiration induced by presbylaryngis, injection laryngoplasty is widely conducted. Here, the feasibility of carboxymethyl cellulose hydrogel modified with pyrogallol (CMC-PG) is checked for injection laryngoplasty. CMC-PG, owing to its low viscosity, is easily injectable in liquid form and can self-polymerize into a hydrogel without the need for oxidative cross-linking agents. Moreover, the CMC-PG hydrogel demonstrates improved stability, tissue adhesiveness, and elastic modulus, compared to a commercial product currently being used for injection laryngoplasty. CMC-PG hydrogel has high binding affinity to various functional moieties and can maintain its structure under swelling condition for an extended period, thereby enabling sustained release of growth factors. CMC-PG is highly biocompatible both in vitro and in vivo, and it does not induce fibrosis or immunogenic responses. Injection of CMC-PG hydrogel encapsulating basic fibroblast growth factor (bFGF) regenerates both the lamina propria and the muscle layer in the vocal folds of an aged rat model, showing increased hyaluronic acids layer and muscle density, enhanced angiogenesis, and modulated immunogenicity. Importantly, bFGF-loaded CMC-PG hydrogel facilitates functional restoration of the aged vocal folds. This study offers clinical potential of CMC-PG hydrogel for injection laryngoplasty for the treatment of presbylaryngis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.